RecruitingPHASE2, PHASE3NCT04390646

GnRH Therapy on Cognition in Down Syndrome

Studying Down syndrome

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Nelly Pitteloud
Principal Investigator
Nelly Pitteloud, MD
Endocrinology, Metabolism, Diabetology (CHUV)
Intervention
GnRH, gonadorelin acetate(drug)
Enrollment
56 enrolled
Eligibility
16-50 years · All sexes
Timeline
20202028

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04390646 on ClinicalTrials.gov

Other trials for Down syndrome

Additional recruiting or active studies for the same condition.

See all trials for Down syndrome

← Back to all trials